phenoxybenzamine has been researched along with Glycogen Storage Disease in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, MG | 1 |
| Neville, SD | 1 |
| Clark, DG | 1 |
1 other study available for phenoxybenzamine and Glycogen Storage Disease
| Article | Year |
|---|---|
Adrenergic regulation of pyruvate kinase and gluconeogenesis in hepatocytes from phosphorylase kinase-deficient (gsd/gsd) rats.
Topics: Animals; Epinephrine; Glucagon; Gluconeogenesis; Glycogen Storage Disease; Liver; Liver Glycogen; Ph | 1981 |